Literature DB >> 18039092

Endocrine functions of adipose tissue.

Hironori Waki1, Peter Tontonoz.   

Abstract

Obesity is a risk factor for type 2 diabetes, dyslipidemia, and cardiovascular disease. Dissection of the molecular mechanisms underlying obesity and its relationship to insulin resistance and the metabolic syndrome are essential for developing new strategies for prevention and treatment of these disorders. Both excess adipose tissue and lack of adipose tissue cause insulin resistance and dyslipidemia, suggesting that normal fat is required for the maintenance of systemic glucose and lipid homeostasis. Recent advances in obesity research have led to the recognition that adipose tissue is an active endocrine organ that secretes multiple bioactive factors termed adipokines. Secretion of adipokines provides a link between adipose tissue lipid accumulation and the metabolic function of other tissues such as liver and muscle. Dysregulation of adipokines is emerging as an important mechanism by which adipose tissue contributes to systemic insulin resistance and metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039092     DOI: 10.1146/annurev.pathol.2.010506.091859

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  115 in total

1.  ClipR-59 plays a critical role in the regulation of body glucose homeostasis.

Authors:  Keyong Du; Sun Yingmin
Journal:  Adipocyte       Date:  2015-05-06       Impact factor: 4.534

2.  Insulin therapy stimulates lipid synthesis and improves endocrine functions of adipocytes in dietary obese C57BL/6 mice.

Authors:  Xiang Chen; Qiu-qiong Yu; Yan-hua Zhu; Yan Bi; Wei-ping Sun; Hua Liang; Meng-ying Cai; Xiao-ying He; Jian-ping Weng
Journal:  Acta Pharmacol Sin       Date:  2010-02-22       Impact factor: 6.150

Review 3.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 4.  The brown fat secretome: metabolic functions beyond thermogenesis.

Authors:  Guo-Xiao Wang; Xu-Yun Zhao; Jiandie D Lin
Journal:  Trends Endocrinol Metab       Date:  2015-04-02       Impact factor: 12.015

Review 5.  Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review.

Authors:  Jennifer F Kawwass; Ross Summer; Caleb B Kallen
Journal:  Mol Hum Reprod       Date:  2015-05-11       Impact factor: 4.025

6.  During Adipocyte Remodeling, Lipid Droplet Configurations Regulate Insulin Sensitivity through F-Actin and G-Actin Reorganization.

Authors:  Jong In Kim; Jeu Park; Yul Ji; Kyuri Jo; Sang Mun Han; Jee Hyung Sohn; Kyung Cheul Shin; Ji Seul Han; Yong Geun Jeon; Hahn Nahmgoong; Kyung Hee Han; Jiwon Kim; Sun Kim; Sung Sik Choe; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2019-09-27       Impact factor: 4.272

7.  A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells.

Authors:  P Dentelli; C Barale; G Togliatto; A Trombetta; C Olgasi; M Gili; C Riganti; M Toppino; M F Brizzi
Journal:  Diabetologia       Date:  2012-10-12       Impact factor: 10.122

8.  A stress signaling pathway in adipose tissue regulates hepatic insulin resistance.

Authors:  Guadalupe Sabio; Madhumita Das; Alfonso Mora; Zhiyou Zhang; John Y Jun; Hwi Jin Ko; Tamera Barrett; Jason K Kim; Roger J Davis
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

9.  A model of insulin resistance in mice, born to diabetic pregnancy, is associated with alterations of transcription-related genes in pancreas and epididymal adipose tissue.

Authors:  Akadiri Yessoufou; Kabirou Moutairou; Naim Akhtar Khan
Journal:  J Obes       Date:  2010-09-26

Review 10.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.